本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

5.62
+0.33006.24%
盘后5.620.00000.00%16:05 EDT
成交量:98.32万
成交额:551.44万
市值:3.84亿
市盈率:-2.55
高:5.74
开:5.35
低:5.33
收:5.29
数据加载中...
2024/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

SEC问询函

Form CORRESP - Correspondence
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities